Loading...
HSChapter 30
U.S. exports of placebos and clinical trial kits for blind or double-blind studies (HS 300693) totaled $69.8M in July 2026.
Importers of Placebos and Clinical Trial Kits for Blind or Double-Blind Studies paid $351K in duties in July 2026 — an effective duty rate of 7.0% on $5.0M in dutiable value, based on actual customs collections rather than the published tariff schedule.
Last updated: July 2026 dataPlacebo preparations and measured-dose clinical trial kits used in blind and double-blind studies occupy a specialized niche in pharmaceutical trade, governed by FDA's Investigational New Drug (IND) framework rather than standard drug approval pathways. The US tariff schedule subdivides this heading across multiple 10-digit lines based on composition — including kits containing sugar at specified thresholds (3006932000), ingredients with nutritional value (3006935000), liquid oral forms (3006936000), and preparations containing non-medicament chemicals (3006938000) — making precise formulation documentation essential for correct classification. China, Spain, and Germany are the leading suppliers, reflecting both contract manufacturing capacity and established clinical research organization networks. Importers must ensure that each shipment is covered by an active IND or equivalent authorization, as clinical trial materials are subject to strict FDA chain-of-custody and labeling requirements.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
227 shipments/mo
The subdivisions under 3006.93 reflect differences in the kit's active or inactive ingredient profile — for example, whether it contains sugar above a threshold (3006932000), ingredients with nutritional value (3006935000), or non-medicament chemicals (3006938000). Importers should obtain a detailed formulation breakdown from the manufacturer and match it against each line's description. Misclassification can affect duty treatment and trigger FDA admissibility questions about the kit's composition.
Clinical trial materials, including placebos, must be imported under an active Investigational New Drug (IND) application or an equivalent FDA authorization. The importer or sponsor must maintain chain-of-custody documentation, and the materials must be labeled in accordance with FDA's IND regulations. Shipments without a valid IND or proper labeling are subject to refusal of admission. Consult a licensed customs broker or regulatory counsel to confirm the specific import requirements for a given trial protocol.
Supplier Network
Get discovered by U.S. importers searching for HS 300693 — Placebos and Clinical Trial Kits for Blind or Double-Blind Studies. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3006931000 | Placebo,Blnd/Dbl-Blnd Clncl Trl Kits,Meas Dos;pkgd | $7.2M | 0.06% | 0.48% | $4K |
| 3006938000 | Placebos Etc Containing Chem Oth Than Medicaments | $6.0M | 5.40% | 78.09% | $324K |
| 3006935000 | Placebo Etc Cont Ingredients W/ Nutritional Value | $1.1M | 0.57% | 5.32% | $6K |
| 3006936000 | Placebos Etc in Liquid Form for Oral Intake | $191K | 0.17% | 92.70% | $317 |
| 3006932000 | Placebo,Blind Clncl Trial Kits, 10 Percent Sugar | $93K | 17.00% | 100.00% | $16K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3006930000 | Placebo,Blind/Dble-Blind Clncl Trial Kits,Meas Dos | $69.8M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$14.6MYoY · Pro
Exports
$69.8MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Exports · July 2026
destination
customs district
origin
entry
rate provision · imports
65.4% enters free of duty; the effective duty rate is 2.41%.